Mark R. Litzow

1.9k total citations
18 papers, 844 citations indexed

About

Mark R. Litzow is a scholar working on Hematology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark R. Litzow has authored 18 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 8 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark R. Litzow's work include Hematopoietic Stem Cell Transplantation (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Polyomavirus and related diseases (5 papers). Mark R. Litzow is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Polyomavirus and related diseases (5 papers). Mark R. Litzow collaborates with scholars based in United States, France and Saudi Arabia. Mark R. Litzow's co-authors include Ayalew Tefferi, Steve G. Peters, Bekele Afessa, David J. Inwards, Mark E. Wylam, Michael J. Krowka, Martha Q. Lacy, Dennis A. Gastineau, James G. Scott and Hassan F. Nadrous and has published in prestigious journals such as Blood, American Journal of Respiratory and Critical Care Medicine and Cancer.

In The Last Decade

Mark R. Litzow

17 papers receiving 830 citations

Peers

Countries citing papers authored by Mark R. Litzow

Since Specialization

Citations

This map shows the geographic impact of Mark R. Litzow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Litzow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Litzow more than expected).

Fields of papers citing papers by Mark R. Litzow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Litzow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Litzow. The network helps show where Mark R. Litzow may publish in the future.

Co-authorship network of co-authors of Mark R. Litzow

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Litzow. A scholar is included among the top collaborators of Mark R. Litzow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Litzow. Mark R. Litzow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Decoding DDX41: Clinical impact of germline and somatic mutations in 77 high-risk myeloid neoplasm patients 2025 ·Blood ·Talha Badar, (unknown), Yael Kusne, (unknown), James M. Foran, Hemant S. Murthy, Mohamed A. Kharfan‐Dabaja, Timothy M. Chlon, Naseema Gangat, Hassan B. Alkhateeb, Abhishek A. Mangaonkar, Rong He, David S. Viswanatha, Jennifer Jiang, Yao‐Shan Fan, Alejandro Ferrer, Mark R. Litzow, Aref Al‐Kali, Mrinal M. Patnaik	0
2	Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study 2021 ·Transplantation and Cellular Therapy ·Matthew D. Seftel, Pintip Chitphakdithai, J. Philip Miller, (unknown), Brent R. Logan, Michael Linenberger, Andrew Artz, Ann E. Haight, David A. Jacobsohn, Mark R. Litzow, Margarida Magalhaes‐Silverman, George B. Selby, Madhuri Vusirikala, Mary M. Horowitz, Galen E. Switzer, Dennis L. Confer, Bronwen E. Shaw, Michael A. Pulsipher	1
3	Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection 2019 ·Biology of Blood and Marrow Transplantation ·Shukaib Arslan, Mark R. Litzow, Nathan W. Cummins, Stacey A. Rizza, Andrew D. Badley, Willis H. Navarro, Shahrukh K. Hashmi	10
4	Utilization and Outcomes of Fertility Preservation Techniques in Women Undergoing Allogeneic Hematopoietic Cell Transplant 2019 ·Biology of Blood and Marrow Transplantation ·(unknown), Zaraq Khan, Charles C. Coddington, Shahrukh K. Hashmi, Mehrdad Hefazi, Hassan B. Alkhateeb, Mark R. Litzow, William J. Hogan, Elizabeth Cathcart-Rake, Carrie A. Thompson, Mrinal M. Patnaik	6
5	Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions 2018 ·Biology of Blood and Marrow Transplantation ·Mehrdad Hefazi, (unknown), Nandita Khera, Jill Adamski, Vivek Roy, Jeffrey L. Winters, Dennis A. Gastineau, Eapen K. Jacob, Justin D. Kreuter, Manish J. Gandhi, William J. Hogan, Mark R. Litzow, Shahrukh K. Hashmi, Hemang Yadav, Vivek Iyer, James G. Scott, Mark E. Wylam, Rodrigo Cartin‐Ceba, Mrinal M. Patnaik	24
6	Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study 2016 ·Biology of Blood and Marrow Transplantation ·Galen E. Switzer, (unknown), (unknown), (unknown), Rebecca Drexler, (unknown), Dennis L. Confer, Mary M. Horowitz, Roberta King, Bronwen E. Shaw, Marcie Riches, Brandon Hayes‐Lattin, Michael Linenberger, Brian J. Bolwell, Scott D. Rowley, Mark R. Litzow, Michael A. Pulsipher	8
7	A perspective on complementary/alternative medicine use among survivors of hematopoietic stem cell transplant: Benefits and uncertainties 2015 ·Cancer ·Rajshekhar Chakraborty, Bipin N. Savani, Mark R. Litzow, Mohamad Mohty, Shahrukh K. Hashmi	12
8	Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation 2014 ·Biology of Blood and Marrow Transplantation ·Hien K. Duong, Bipin N. Savani, Ed Copelan, Steven M. Devine, Luciano J. Costa, John R. Wingard, Paul Shaughnessy, Navneet S. Majhail, Miguel‐Angel Perales, Corey Cutler, William Bensinger, Mark R. Litzow, Mohamad Mohty, Richard E. Champlin, Helen Leather, Sergio Giralt, Paul A. Carpenter	140
9	Antigen-based immunotherapy for the treatment of acute lymphoblastic leukemia: the emerging role of blinatumomab 2014 ·ImmunoTargets and Therapy ·Mark R. Litzow	3
10	Progressive Multifocal Leukoencephalopathy: a rare infectious complication following allogeneic hematopoietic cell transplantation (HCT) 2013 ·European Journal Of Haematology ·Gregory P. Kaufman, Allen J. Aksamit, Christopher J. Klein, Eunhee S. Yi, David R. DeLone, Mark R. Litzow	19
11	Pharmacotherapeutic advances in the treatment of acute lymphoblastic leukaemia in adults. 2011 ·PubMed ·Mark R. Litzow	8
12	Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma 2008 ·British Journal of Haematology ·Luciano J. Costa, Ivana N. Micallef, David J. Inwards, Patrick B. Johnston, Luis F. Porrata, Mark R. Litzow, Stephen M. Ansell	18
13	Pulmonary Complications in Adult Blood and Marrow Transplant Recipients 2005 ·CHEST Journal ·Sunita Sharma, Hassan F. Nadrous, Steve G. Peters, Ayalew Tefferi, Mark R. Litzow, Marie-Christine Aubry, Bekele Afessa	101
14	Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis 2005 ·European Journal of Clinical Microbiology & Infectious Diseases ·Rajesh M. Prabhu, Kerryl E. Piper, Mark R. Litzow, James M. Steckelberg, Robin Patel	37
15	Posttransplantation Thrombotic Thrombocytopenic Purpura: A Single-Center Experience and a Contemporary Review 2003 ·Mayo Clinic Proceedings ·Michelle A. Elliott, William L. Nichols, Elizabeth Plumhoff, Stephen M. Ansell, Angela Dispenzieri, Dennis A. Gastineau, Morie A. Gertz, David J. Inwards, Martha Q. Lacy, Ivana N. Micallef, Ayalew Tefferi, Mark R. Litzow	83
16	Outcome of Diffuse Alveolar Hemorrhage in Hematopoietic Stem Cell Transplant Recipients 2002 ·American Journal of Respiratory and Critical Care Medicine ·Bekele Afessa, Ayalew Tefferi, Mark R. Litzow, Steve G. Peters	95
17	Diffuse Alveolar Hemorrhage in Hematopoietic Stem Cell Transplant Recipients 2002 ·American Journal of Respiratory and Critical Care Medicine ·Bekele Afessa, Ayalew Tefferi, Mark R. Litzow, Michael J. Krowka, Mark E. Wylam, Steve G. Peters	132
18	Late‐onset noninfectious pulmonary complications after allogeneic bone marrow transplantation 1998 ·British Journal of Haematology ·Angelo Palmas, Ayalew Tefferi, Jeffrey L. Myers, James G. Scott, Stephen J. Swensen, (unknown), Dennis A. Gastineau, (unknown), David J. Inwards, Martha Q. Lacy, Mark R. Litzow	147

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact